Evidence mapPaperPMID 28291223Full record

ArticleScientific reports2017

Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE

Marco Busnelli, Stefano Manzini, Mika Hilvo, Cinzia Parolini, Giulia S Ganzetti, Federica Dellera, Kim Ekroos, Minna Jänis, Diana Escalante-Alcalde, Cesare R Sirtori and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.International journal of molecular sciences · 2021
    Review
  13. Review
  14. Article
  15. Review
  16. Coronary Artery Disease Risk-AssociatedArteriosclerosis, thrombosis, and vascular biology · 2019
    Article
  17. Article
  18. Review
  19. Molecular mechanisms and genetic regulation in atherosclerosis.International journal of cardiology. Heart & vasculature · 2018
    Review
  20. Lysophosphatidic acid acts on LPABritish journal of pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Marco BusnelliDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Stefano ManziniDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Mika HilvoZora Biosciences Oy, Espoo, Finland.
Cinzia ParoliniDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Giulia S GanzettiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Federica DelleraDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Kim EkroosZora Biosciences Oy, Espoo, Finland.
Minna JänisDepartment of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland.
Diana Escalante-AlcaldeInstituto de Fisiología Celular, División de Neurociencias Universidad Nacional Autónoma de México, Cd. Mx. 04510, México.
Cesare R SirtoriDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
Reijo LaaksonenZora Biosciences Oy, Espoo, Finland.
Giulia ChiesaDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy.
University of Milan · ITZora Biosciences (Finland) · FIUniversidad Nacional Autónoma de México · MXUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The PLPP3 gene encodes for a ubiquitous enzyme that dephosphorylates several lipid substrates. Genome-wide association studies identified PLPP3 as a gene that plays a role in coronary artery disease susceptibility. The aim of the study was to investigate the effect of Plpp3 deletion on atherosclerosis development in mice. Because the constitutive deletion of Plpp3 in mice is lethal, conditional Plpp3 hepatocyte-specific null mice were generated by crossing floxed Plpp3 mice with animals expressing Cre recombinase under control of the albumin promoter. The mice were crossed onto the athero-prone apoE

Indexed as

AnimalsAortaApolipoproteins EAtherosclerosisDiet, WesternDisease Models, AnimalGene DeletionHepatocytesHumansLipid MetabolismLipidsLiverMiceMice, KnockoutOrgan SpecificityPhosphatidate PhosphataseApolipoproteins ELipidsPhosphatidate PhosphatasePlpp3 protein, mouse

Identifiers

PMID28291223
PMCPMC5349609
OpenAlexW2640824658

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.